THE EFFECT OF COMPLETE RESECTION OF CONTRAST-ENHANCING TUMOR ON SURVIVAL IN PATIENTS WITH GLIOBLASTOMA OVER A 16-YEAR PERIOD IN A GEOGRAPHICALLY DEFINED POPULATION

被引：0
|
作者：
Mireles, Eduardo Erasmo Mendoza [1 ]
Vik-Mo, Einar Osland [1 ]
Skaga, Erlend [1 ]
Helseth, Eirik [1 ]
Ronning, Pal Andre [1 ]
Server, Andres [1 ]
Brandal, Petter [1 ]
机构：
[1] Oslo Univ Hosp, Oslo, Norway
来源：
NEURO-ONCOLOGY | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
QLTI-01
引用
收藏
页码：234 / 234
页数：1
相关论文
共 9 条
  • [1] Spatial invasion patterns of temporal lobe glioblastoma after complete resection of contrast-enhancing tumor
    Fares, Jawad
    Wan, Yizhou
    Gurung, Binay
    Nazar, Thaaqib
    Mair, Richard
    Joannides, Alexis
    Santarius, Thomas
    Matys, Tomasz
    Price, Stephen J.
    JOURNAL OF NEURO-ONCOLOGY, 2025,
  • [2] Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial
    Suchorska, Bogdana
    Weller, Michael
    Tabatabai, Ghazaleh
    Senft, Christian
    Hau, Peter
    Sabel, Michael C.
    Herrlinger, Ulrich
    Ketter, Ralf
    Schlegel, Uwe
    Marosi, Christine
    Reifenberger, Guido
    Wick, Wolfgang
    Tonn, Joerg C.
    Wirsching, Hans-Georg
    NEURO-ONCOLOGY, 2016, 18 (04) : 549 - 556
  • [3] The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study
    Mireles, Eduardo Erasmo Mendoza
    Skaga, Erlend
    Server, Andres
    Leske, Henning
    Brandal, Petter
    Helseth, Eirik
    Ronning, Pal A.
    Vik-Mo, Einar O.
    NEURO-ONCOLOGY PRACTICE, 2023, 10 (06) : 555 - 564
  • [4] The influence of maximum safe resection of T1 contrast-enhancing tumor and T2 FLAIR abnormality on survival in 1229 glioblastoma patients
    Li, Yan Michael
    Suki, Dima
    Sawaya, Raymond
    JOURNAL OF NEUROSURGERY, 2015, 123 (02) : A485 - A485
  • [5] Complete resection of contrast enhancing tumor volume is associated with improved survival in recurrent glioblastoma - results from the DIRECTOR trial
    Wirsching, H. -G.
    Tonn, J. C.
    Tabatabai, G.
    Senft, C.
    Hau, P.
    Sabel, M. C.
    Herrlinger, U.
    Ketter, R.
    Schlegel, U.
    Marosi, C.
    Reifenberger, G.
    Wick, W.
    Weller, M.
    Suchorska, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 921 - 922
  • [6] Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998–2013): a population-based analysis
    M. Rottmann
    T. Beck
    A. Burges
    C. Dannecker
    M. Kiechle
    D. Mayr
    A. Schlesinger-Raab
    G. Schubert-Fritschle
    J. Engel
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 1331 - 1341
  • [7] Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998-2013): a population-based analysis
    Rottmann, M.
    Beck, T.
    Burges, A.
    Dannecker, C.
    Kiechle, M.
    Mayr, D.
    Schlesinger-Raab, A.
    Schubert-Fritschle, G.
    Engel, J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (06) : 1331 - 1341
  • [8] Patterns of care and survival of Chinese glioblastoma patients in the temozolomide era: a Hong Kong population-level analysis over a 14-year period
    Woo, Peter Y. M.
    Yau, Stephen
    Lam, Tai-Chung
    Pu, Jenny K. S.
    Li, Lai-Fung
    Lui, Louisa C. Y.
    Chan, Danny T. M.
    Loong, Herbert H. F.
    Lee, Michael W. Y.
    Yeung, Rebecca
    Kwok, Carol C. H.
    Au, Siu-Kie
    Tan, Tze-Ching
    Kan, Amanda N. C.
    Chan, Tony K. T.
    Mak, Calvin H. K.
    Mak, Henry K. F.
    Ho, Jason M. K.
    Cheung, Ka-Man
    Tse, Teresa P. K.
    Lau, Sarah S. N.
    Chow, Joyce S. W.
    El-Helali, Aya
    Ng, Ho-Keung
    Poon, Wai-Sang
    NEURO-ONCOLOGY PRACTICE, 2023, 10 (01) : 50 - 61
  • [9] Trends in Chemotherapy Patterns and Survival of Patients with Advanced Gastric Cancer over a 16-Year Period: Impact of Anti-HER2-Targeted Agent in the Real-World Setting
    Koo, Dong-Hoe
    Ryu, Min-Hee
    Lee, Mi-Yeon
    Chae, Heejung
    Kim, Eo Jin
    Moon, Mee-Sun
    Kang, Yoon-Koo
    CANCER RESEARCH AND TREATMENT, 2021, 53 (02): : 436 - 444
1